The Influence of Socioeconomic Status on Racial/Ethnic Disparities among the ER/PR/HER2 Breast Cancer Subtypes

Journal of Cancer Epidemiology

Volumn 2015, Issue , 2015, Pages

  Parise, Carol A ^a   Caggiano, Vincent ^a  

^a Sutter Institute for Medical Research ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84939833122     PISSN: 16878558     EISSN: 16878566     Source Type: Journal    
DOI: 10.1155/2015/813456     Document Type: Article

References (89)

1. L. Ries, M. Eisner, and M. Kosary, SEER Cancer Statistics Review, 1975-2000, National Cancer Institute, Bethesda, Md, USA, 2003.
2. J. H. Silber, P. R. Rosenbaum,A. S. Clark et al., "Characteristics associated with differences in survival among black and white women with breast cancer," Journal of the American Medical Association, vol. 310, no. 4, pp. 389-397, 2013.
3. S. L. Tannenbaum, T. Koru-Sengul, F. Miao, and M. M. Byrne, "Disparities in survival after female breast cancer diagnosis: a population-based study," Cancer Causes and Control, vol. 24,no. 9, pp. 1705-1715, 2013.
4. C. Parise and V. Caggiano, "Disparities in the risk of the ER/ PR/HER2 breast cancer subtypes among Asian Americans in California," Cancer Epidemiology, vol. 38, no. 5, pp. 556-562, 2014.
5. J. Iqbal, O. Ginsburg, P. A. Rochon, P. Sun, and S. A. Narod, "Differences in breast cancer stage at diagnosis and cancerspecific survival by race and ethnicity in the United States," Journal of the American Medical Association, vol. 313, no. 2, pp. 165-173, 2015.
6. V. L. Shavers, L. C.Harlan, and J. L. Stevens, "Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35," Cancer, vol. 97, no. 1, pp. 134-147, 2003.
7. R. T. Chlebowski, Z. Chen, G. L. Anderson et al., "Ethnicity and breast cancer: factors influencing differences in incidence and outcome," Journal of the National Cancer Institute, vol. 97, no. 6, pp. 439-448, 2005.
8. D. Hershman, R. McBride, J. S. Jacobson et al., "Racial disparities in treatment and survival among women with early-stage breast cancer," Journal of Clinical Oncology, vol. 23, no. 27, pp. 6639-6646, 2005.
9. I. Menashe, W. F. Anderson, I. Jatoi, and P. S. Rosenberg, "Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis," Journal of the National Cancer Institute, vol. 101, no. 14, pp. 993-1000, 2009.
10. L. Vona-Davis and D. P. Rose, "The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review," Journal of Women's Health, vol. 18, no. 6, pp. 883-893, 2009.
11. A. D. Deshpande, D. B. Jeffe, J. Gnerlich, A. Z. Iqbal, A. Thummalakunta, and J. A. Margenthaler, "Racial disparities in breast cancer survival: an analysis by age and stage," Journal of Surgical Research, vol. 153, no. 1, pp. 105-113, 2009.
12. A. Bhargava and X. L. Du, "Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer," Cancer, vol. 115, no. 13, pp. 2999-3008, 2009.
13. O. W. Brawley, "Health disparities in breast cancer," Obstetrics and Gynecology Clinics of North America, vol. 40, no. 3, pp. 513-523, 2013.
14. S. B.Wheeler, K. E. Reeder-Hayes, and L. A. Carey, "Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research," Oncologist, vol. 18, no. 9, pp. 986-993, 2013.
15. M. Roach III, C. Cirrincione, D. Budman et al., "Race and survival from breast cancer: based on Cancer and Leukemia Group B trial 8541," Cancer Journal from Scientific American, vol. 3, no. 2, pp. 107-112, 1997.
16. E. Curtis, C. Quale, D. Haggstrom, and R. Smith-Bindman, "Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics?" Cancer, vol. 112, no. 1, pp. 171-180, 2008.
17. X. L. Du, S. Fang, and T. E. Meyer, "Impact of treatment and socioeconomic status on racial disparities in survival among older women with breast cancer," American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 31,no. 2, pp. 125-132, 2008.
18. Q. D. Chu, M. H. Smith, M.Williams et al., "Race/ethnicity has no effect on outcome for breast cancer patients treated at an academic center with a public hospital," Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 8, pp. 2157-2161, 2009.
19. I. K. Komenaka, M. E. Martinez, R. E. Pennington et al., "Race and ethnicity and breast cancer outcomes in an underinsured population," Journal of the National Cancer Institute, vol. 102, no. 15, pp. 1178-1187, 2010.
20. L. A. Newman, K. A. Griffith, I. Jatoi, M. S. Simon, J. P. Crowe, and G. A. Colditz, "Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status," Journal of Clinical Oncology, vol. 24, no. 9, pp. 1342-1349, 2006.
21. K. S. Albain, J. M. Unger, J. J. Crowley, C. A. Coltman, and D. L. Hershman, "Racial disparities in cancer survival among randomized clinical trials patients of the southwest oncology group," Journal of the National Cancer Institute, vol. 101, no. 14, pp. 984-992, 2009.
22. T. H. Keegan, A. W. Kurian, K. Gali et al., "Racial/ethnic and socioeconomic differences in short-term breast cancer survival among women in an integrated health system," American Journal of Public Health, vol. 105, no. 5, pp. 938-946, 2015.
23. C. J. Bradley, C.W.Given, andC.Roberts, "Race, socioeconomic status, and breast cancer treatment and survival," Journal of the National Cancer Institute, vol. 94, no. 7, pp. 490-496, 2002.
24. T. E. Byers, H. J. Wolf, K. R. Bauer et al., "The impact of socioeconomic status on survival after cancer in the United States: findings fromtheNational Programof Cancer Registries patterns of care study," Cancer, vol. 113, no. 3, pp. 582-591, 2008.
25. B. L. Sprague, A. Trentham-Dietz, R. E. Gangnon et al., "Socioeconomic status and survival after an invasive breast cancer diagnosis," Cancer, vol. 117, no. 7, pp. 1542-1551, 2011.
26. C. A. Parise, K. R. Bauer, M. M. Brown, and V. Caggiano, "Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004," The Breast Journal, vol. 15, no. 6, pp. 593-602, 2009.
27. C. D. O'Malley, G. M. Le, S. L. Glaser, S. J. Shema, and D.W. West, "Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study," Cancer, vol. 97, no. 5, pp. 1303-1311, 2003.
28. A. G. Fritz, International Classification of Diseases for Oncology: ICD-O, World Health Organization, Geneva, Switzerland, 3rd edition, 2000.
29. California Department of Public; Cancer Surveillance and Research Branch, "Cancer reporting in California: abstracting and coding procedures for hospitals," in California Cancer Reporting System Standards, vol. 1, California Department of Public, Cancer Surveillance and Research Branch, Sacramento, Calif, USA, 2008.
30. American Community Survey, US Department of Commerce, United States Census Bureau , 2014, https://www.census.gov/ acs/www/data documentation/summary file/.
31. K. Yost, C. Perkins, R. Cohen, C. Morris, andW. Wright, "Socioeconomic status and breast cancer incidence in California for different race/ethnic groups," Cancer Causes and Control, vol. 12, no. 8, pp. 703-711, 2001.
32. K. R. Bauer, M. Brown, C. Creech, N. C. Schlag, and V. Caggiano, "Data quality assessment of HER2 in the Sacramento region of the California cancer registry," Journal of Registry Management, vol. 34, no. 1, pp. 4-7, 2007.
33. M. Brown, A. Tsodikov, K. R. Bauer, C. A. Parise, and V. Caggiano, "The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004," Cancer, vol. 112, no. 4, pp. 737-747, 2008.
34. C. A. Clarke, S. L. Glaser, T. H. M. Keegan, and A. Stroup, "Neighborhood socioeconomic status and Hodgkin's lymphoma incidence in California," Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 6, pp. 1441-1447, 2005.
35. A. Parikh-Patel, P. K. Mills, and R. V. Jain, "Breast cancer survival among South Asian women in California (United States)," Cancer Causes and Control, vol. 17, no. 3, pp. 267-272, 2006.
36. C.A.Parise, K. R. Bauer, andV.Caggiano, "Disparities in receipt of adjuvant radiation therapy after breast-conserving surgery among the cancer-reporting regions of California," Cancer, vol. 118, no. 9, pp. 2516-2524, 2012.
37. K. Bauer, C. Parise, and V. Caggiano, "Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer," BMC Cancer, vol. 10, article 228, 2010.
38. K. R. Bauer, M. Brown, R. D. Cress, C. A. Parise, and V. Caggiano, "Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry," Cancer, vol. 109, no. 9, pp. 1721-1728, 2007.
39. IBM, IBM SPSS Statistics for Windows, Version 21.0, IBM, Armonk, NY, USA, 2012.
40. C.M. Perou, T. Sørile, M. B. Eisen et al., "Molecular portraits of human breast tumours," Nature, vol. 406, no. 6797, pp. 747-752, 2000.
41. T. Sørlie, R. Tibshirani, J. Parker et al., "Repeated observation of breast tumor subtypes in independent gene expression data sets," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8418-8423, 2003.
42. L. A. Carey, C. M. Perou, C. A. Livasy et al., "Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study," Journal of theAmericanMedical Association, vol. 295, no. 21, pp. 2492-2502, 2006.
43. M. C.U. Cheang, K. D. Voduc, D. Tu et al., "Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial," Clinical Cancer Research, vol. 18, no. 8, pp. 2402-2412, 2012.
44. L.K.Dunnwald,M. A. Rossing, andC. I.Li, "Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients," Breast Cancer Research, vol. 9, no. 1, article R6, 2007.
45. C. A. Parise, K. R. Bauer, and V. Caggiano, "Variation in breast cancer subtypes with age and race/ethnicity," Critical Reviews in Oncology/Hematology, vol. 76, no. 1, pp. 44-52, 2010.
46. A.W. Kurian, K. Fish, S. J. Shema, and C. A. Clarke, "Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups," Breast Cancer Research, vol. 12, no. 6, article R99, 2010.
47. B. K. Dunn, T. Agurs-Collins, D. Browne, R. Lubet, and K. A. Johnson, "Health disparities in breast cancer: biology meets socioeconomic status," Breast Cancer Research and Treatment, vol. 121, no. 2, pp. 281-292, 2010.
48. C. A. Clarke, T. H. M. Keegan, J. Yang et al., "Age-specific incidence of breast cancer subtypes: understanding the blackwhite crossover," Journal of the National Cancer Institute, vol. 104, no. 14, pp. 1094-1101, 2012.
49. A. Prat, L. A. Carey, B. Adamo et al., "Molecular features and survival outcomes of the intrinsic subtypes within HER2- positive breast cancer," Journal of the National Cancer Institute, vol. 106, no. 8, 2014.
50. H. M. Sineshaw, M. Gaudet, E. M. Ward et al., "Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in theNationalCancerData Base (2010-2011)," Breast Cancer Research and Treatment, vol. 145, no. 3, pp. 753-763, 2014.
51. N. Howlader, S. F. Altekruse, C. I. Li et al., "US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status," Journal of the National Cancer Institute, vol. 106, no. 5, 2014.
52. W. F. Anderson, P. S. Rosenberg, and H. A. Katki, "Tracking and evaluating molecular tumor markers with cancer registry data: HER2 and breast cancer," Journal of the National Cancer Institute, vol. 106, no. 5,Article ID dju093, 2014.
53. P. Maisonneuve, D. Disalvatore, N. Rotmensz et al., "Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes," Breast Cancer Research, vol. 16, no. 3, article R65, 2014.
54. A. Goldhirsch, A. S. Coates, R. D. Gelber, J. H. Glick, B. Thürlimann, and H.-J. Senn, "First-select the target: better choice of adjuvant treatments for breast cancer patients," Annals of Oncology, vol. 17, no. 12, pp. 1772-1776, 2006.
55. O. Brouckaert, A. Schoneveld, C. Truyers et al., "Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancers," Annals of Oncology, vol. 24, no. 7, Article IDmdt179, pp. 1847-1852, 2013.
56. M. J. Engstrøm, S. Opdahl, A. I. Hagen et al., "Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients," Breast cancer research and treatment, vol. 140, no. 3, pp. 463-473, 2013.
57. C. A. Parise and V. Caggiano, "Disparities in race/ethnicity and socioeconomic status: risk ofmortality of breast cancer patients in theCaliforniaCancer Registry, 2000-2010,"BMCCancer, vol. 13, article 449, 2013.
58. A. H. Wu, S. L. Gomez, C. Vigen et al., "The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival," Cancer Causes and Control, vol. 24, no. 10, pp. 1821-1836, 2013.
59. Q. D. Trinh, P. L. Nguyen, J. J. Leow et al., "Cancer-specific mortality of Asian Americans diagnosed with cancer: a nationwide population-based assessment," Journal of the National Cancer Institute, vol. 107, no. 6, 2015.
60. L.A. Stead,T.L.Lash, J. E. Sobieraj et al., "Triple-negative breast cancers are increased in black women regardless of age or body mass index," Breast Cancer Research, vol. 11, no. 2, article R18, 2009.
61. K. C. Amirikia, P. Mills, J. Bush, and L. A. Newman, "Higher population-based incidence rates of triple-negative breast cancer among young African-American women: implications for breast cancer screening recommendations," Cancer, vol. 117, no. 12, pp. 2747-2753, 2011.
62. L. A. Newman, "Disparities in breast cancer and african ancestry: a global perspective," Breast Journal, vol. 21, no. 2, pp. 133-139, 2015.
63. A. A. Aizer, T. J.Wilhite, M.-H. Chen et al., "Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period," Cancer, vol. 120, no. 10, pp. 1532-1539, 2014.
64. B. R.Hunt, S. Whitman, andM. S.Hurlbert, "Increasing black: white disparities in breast cancer mortality in the 50 largest cities in the United States," Cancer Epidemiology, vol. 38, no. 2, pp. 118-123, 2014.
65. S. L. Gomez and S. L. Glaser, "Misclassification of race/ethnicity in a population-based cancer registry (United States)," Cancer Causes and Control, vol. 17, no. 6, pp. 771-781, 2006.
66. A. E. Dragun, B. Huang, T. C. Tucker, and W. J. Spanos, "Disparities in the application of adjuvant radiotherapy after breastconserving surgery for early stage breast cancer," Cancer, vol. 117, no. 12, pp. 2590-2598, 2011.
67. N. A. Bickell, J. J.Wang, S.Oluwole et al., "Missed opportunities: racial disparities in adjuvant breast cancer treatment," Journal of Clinical Oncology, vol. 24, no. 9, pp. 1357-1362, 2006.
68. M. J. Lund, O. P. Brawley, K. C. Ward, J. L. Young, S. S. G. Gabram, and J. W. Eley, "Parity and disparity in first course treatment of invasive breast cancer," Breast Cancer Research and Treatment, vol. 109, no. 3, pp. 545-557, 2008.
69. C. I. Li, J. R. Daling, and K. E. Malone, "Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998," Journal of Clinical Oncology, vol. 21, no. 1, pp. 28-34, 2003.
70. N. T. van Ravesteyn, C. B. Schechter, A. M. Near et al., "Racespecific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States," Cancer Epidemiology Biomarkers and Prevention, vol. 20, no. 1, pp. 112-122, 2011.
71. H. B. Muss, C. P. Hunter, M. Wesley et al., "Treatment plans for black and white women with stage II node-positive breast cancer: the National Cancer Institute Black/White Cancer Survival Study Experience," Cancer, vol. 70, no. 10, pp. 2460-2467, 1992.
72. L.C.Harlan, J. Abrams, J. L.Warren, L. Clegg, J. Stevens, andR. Ballard-Barbash, "Adjuvant therapy for breast cancer: practice patterns of community physicians," Journal of ClinicalOncology, vol. 20, no. 7, pp. 1809-1817, 2002.
73. J. J. Griggs, "Role of nonclinical factors in the receipt of highquality systemic adjuvant breast cancer treatment," Journal of Clinical Oncology, vol. 30, no. 2, pp. 121-124, 2012.
74. A. Parikh-Patel, J. H. Bates, and S. Campleman, "Colorectal cancer stage at diagnosis by socioeconomic and urban/rural status in California, 1988-2000," Cancer, vol. 107, supplement 5, pp. 1189-1195, 2006.
75. J. A. Zell, J. M. Rhee, A. Ziogas, S. M. Lipkin, and H. Anton- Culver, "Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California," Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 3, pp. 546-552, 2007.
76. N. Krieger, "Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology," American Journal of Public Health, vol. 82, no. 5, pp. 703-710, 1992.
77. V. L. Shavers, "Measurement of socioeconomic status in health disparities research," Journal of the National Medical Association, vol. 99, no. 9, pp. 1013-1023, 2007.
78. T. F. Akinyemiju, A. S. Soliman, N. J. Johnson et al., "Individual and neighborhood socioeconomic status and healthcare resources in relation to black-white breast cancer survival disparities," Journal of Cancer Epidemiology, vol. 2013, Article ID 490472, 13 pages, 2013.
79. J. K. Kish, M. Yu, A. Percy-Laurry, and S. F. Altekruse, "Racial and ethnic disparities in cancer survival by neighborhood socioeconomic status in Surveillance, Epidemiology, and End Results (SEER) Registries," JNCI Monographs, vol. 2014, no. 49, pp. 236-243, 2014.
80. S. Shariff-Marco, J. Yang, E. M. John et al., "Impact of neighborhood and individual socioeconomic status on survival after breast cancer varies by race/ethnicity: the neighborhood and breast cancer study," Cancer Epidemiology Biomarkers and Prevention, vol. 23, no. 5, pp. 793-811, 2014.
81. G. Ursin, L. Bernstein, S. J. Lord et al., "Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology," British Journal of Cancer, vol. 93, no. 3, pp. 364-371, 2005.
82. H. Ma, L. Bernstein, M. C. Pike, and G. Ursin, "Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: ameta-analysis of epidemiological studies," Breast Cancer Research, vol. 8, no. 4, article R43, 2006.
83. S. S. Shinde, M. R. Forman, H. M. Kuerer et al., "Higher parity and shorter breastfeeding duration: association with triplenegative phenotype of breast cancer," Cancer, vol. 116, no. 21, pp. 4933-4943, 2010.
84. D. Yin, C. Morris, M. Allen, R. Cress, J. Bates, and L. Liu, "Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups?" Cancer Causes and Control, vol. 21, no. 10, pp. 1721-1730, 2010.
85. H. R.Harris,W. C.Willett, K. L. Terry, and K. B.Michels, "Body fat distribution and risk of premenopausal breast cancer in the Nurses'Health Study II," Journal of theNational Cancer Institute, vol. 103, no. 3, pp. 273-278, 2011.
86. L. Bernstein and J. V. Lacey Jr., "Receptors, associations, and risk factor differences by breast cancer subtypes: positive or negative?" Journal of the National Cancer Institute, vol. 103, no. 6, pp. 451-453, 2011.
87. A. I. Phipps and C. I. Li, "Breastfeeding and triple-negative breast cancer: potential implications for racial/ethnic disparities," Journal of the National Cancer Institute, vol. 106, no. 10, 2014.
88. S. Sieri, P. Chiodini, C. Agnoli et al., "Dietary fat intake and development of specific breast cancer subtypes," Journal of the National Cancer Institute, vol. 106, no. 5,Article IDdju068, 2014.
89. N. K. Khankari, P. T. Bradshaw, S. E. Steck et al., "Dietary intake of fish, polyunsaturated fatty acids, and survival after breast cancer: a population-based follow-up study on Long Island, New York," Cancer, vol. 121, no. 13, pp. 2244-2252, 2015.